Key Findings:  Following the cannabis treatment, behavioral outbreaks were much improved or very much improved in 61% of patients. This preliminary study supports feasibility of CBD-based cannabis trials in children with ASD.
Type of Study:  Clinical Trial
Study Sample Size:  60
Study Result:  Positive
Study Location(s):  Israel
Year of Pub:  2019
Cannabinoids Studied:  Cannabidiol (CBD), Tetrahydrocannabinol (THC)
Phytocannabinoid Source:  Unspecified
Chemotype:  Chemotype III